Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Rituximab Treatment Report
What is Rituximab?

Rituximab is an injectable drug that is in a class of medications called monoclonal antibiodies. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 10 1
Slow my MS progress 9 3
Exacerbation (relapse) MS 2 0
experimental 1 0
Brain fog 1 0
disease-related symptoms 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 25%
None
3 75%

Most commonly reported side effects

Migraine
1 25%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Rituximab. See all 15 dosages ►

  10 mg all the time (24/7) 10 mg as needed 10mg/mL as needed 1g as needed 500mg as needed 7hours as needed as needed daily 1 other yearly 10 mg yearly 10 mg every 3 months 500 mg yearly 500 mg every 3 months 100 mg one time 1000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Rituximab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended
6 67% Course of treatment ended: 67%
Other
2 22% Other: 22%
Did not seem to work
1 11% Did not seem to work: 11%
Doctor's advice
1 11% Doctor's advice: 11%

See all 9 patients who’ve stopped taking Rituximab

Duration See details about how long patients take this treatment ▼

Currently Taking Rituximab

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
4
3

Stopped Taking Rituximab

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
2
0
1
1
1

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
4 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 25%
A little
3 75%
Not at all
0 0%

Cost

Paid out of pocket

$200+
1 25%
$100-199
2 50%
$50-99
0 0%
$25-49
0 0%
< $25
1 25%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.